ExSight’s Early Success Opening Door for New Fund?

Firas M. Rahhal, MD, a partner at ExSight Capital, had his hands full with his surgery practice in LA. But when a few high-profile patients prodded a fellow surgeon into creating an early-stage fund to invest in ophthalmology, Dr. Rahhal decided he could build a few more hours into his week to become a venture capitalist. The small fund made three investments, including one in gene therapy company RetroSense, which was acquired by Allergan last year. What’s next for the upstart VC?

STAY UP TO DATE WITH OIS

Get the Latest News, Podcasts and Videos.